Skip to main content
Top

Breast Cancer Research and Treatment

Issue 2/2005

Content (11 Articles)

Report

Polymorphisms of the BRCA2 and RAD51 Genes in Breast Cancer

Tomasz Sliwinski, Renata Krupa, Ireneusz Majsterek, Jan Rykala, Agnieszka Kolacinska, Zbigniew Morawiec, Jozef Drzewoski, Marek Zadrozny, Janusz Blasiak

Report

High Incidence of 4153delA BRCA1 Gene Mutations in Lithuanian Breast- and Breast-ovarian Cancer Families

Jacek Gronwald, Pavel Elsakov, Bohdan Górski, Jan Lubiński

Epidemiology

Mammographic Breast Density and the Gail Model for Breast Cancer Risk Prediction in a Screening Population

Jeffrey A. Tice, Steven R. Cummings, Elad Ziv, Karla Kerlikowske

Report

A Cost-effectiveness Analysis of Two Rehabilitation Support Services for Women with Breast Cancer

Louisa G. Gordon, Paul Scuffham, Diana Battistutta, Nick Graves, Margaret Tweeddale, Beth Newman

Report

Serum Lipids and Outcome of Early-stage Breast Cancer: Results of a Prospective Cohort Study

Mala Bahl, Marguerite Ennis, Ian F. Tannock, Jan E. Hux, Kathleen I. Pritchard, Jarley Koo, Pamela J. Goodwin

Report

Estrogen Receptor Beta (ESR2) Polymorphisms in Familial and Sporadic Breast Cancer

Paula Maguire, Sara Margolin, Johanna Skoglund, Xiao-Feng Sun, Jan-Åke Gustafsson, Anne-Lise Børresen-Dale, Annika Lindblom

Report

Progesterone Pre-treatment Potentiates EGF Pathway Signaling in The Breast Cancer Cell Line ZR-75*

A. Carvajal, N. Espinoza, S. Kato, M. Pinto, A. Sadarangani, C. Monso, E. Aranda, M. Villalon, J. K. Richer, K. B. Horwitz, J. J. Brosens, G. I. Owen

Report

Tissue Inhibitor of Metalloproteinases-1 Stimulates Gene Expression in MDA-MB-435 Human Breast Cancer Cells by Means of its Ability to Inhibit Metalloproteinases

Joseph F. Porter, Shashi Sharma, Donna L. Wilson, Maya A. Kappil, Ronald P. Hart, David T. Denhardt

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine